cabozantinib
Not Tagged
['cabo ', 'rcc,(-irccs),(-srcc),(-urcc)']
rw outcomes for pts w/ mrcc rx-ed w/ cabo or other tkis after cpi therapy n=485 adj rw rr over first 6 months: 62.5% for cabo and 46.0% for other tkis no diff in os; numerical improvement in time to next rx for cabo vs other tkis #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor